Perrigo Company Plc (NYSE:PRGO) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET
Company Participants
Brad Joseph - Vice President, Investor Relations
Patrick Taylor - President and Chief Executive Officer
Eduardo Bezerra - Executive Vice President and Chief Financial Officer
Conference Call Participants
Chris Schott - JPMorgan
Susan Anderson - Canaccord Genuity
Daniel Biolsi - Hedgeye
Keonhee Kim - Morning Star
Operator
Good Day and welcome to the Perrigo Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator instructions]. Please also note this event is being recorded.
At this time, I would now like to turn the floor over to Bradley Joseph, VP and Investor Relations. Sir, please go ahead.
Brad Joseph
Good morning, and welcome to Perrigo’s third quarter 2023 earnings conference call. I hope you all had a chance to review our release issued this morning. A copy of the earnings release and presentation for today’s discussion are available within the Investors section of perrigo.com website.
Joining today’s call are President and CEO Patrick Lockwood-Taylor and CFO, Eduardo Bezerra. I would like to remind everyone that during this call, participants will make certain forward-looking statements. Please refer to the important information for shareholders and investors and Safe Harbor language regarding these statements in our press release issued earlier this morning.
A few quick items before we start. First, unless stated, all financial results discussed and presented are on a continuing operations basis. They do not include any contributions from the divested Rx business, which was accounted for as discontinued operations prior to its sale.
Second, organic growth excludes acquisitions, divestitures, exited product lines and currency in both comparable periods. All comments related to constant currency remove the impact of currency translation versus the prior year by applying the exchange rates used in the comparable measurements in the prior year's financial statements.
And third, Patrick’s discussion will focus solely on non-GAAP results, except as otherwise noted. See the appendix for additional details and for reconciliations of all non-GAAP financial measures presented.
As for today's agenda, Patrick will cover our solid quarterly financial results and strong business fundamentals. He will then discuss the evolving dynamics in the infant formula industry followed by our excitement for the anticipated launch of Opill.
He will then round out his comments with reflections after four months of CEO, provide an update on our strategy to build a sustainable and value accretive growth engine, and end with area of focus to close 2023. Eduardo will then walk through the financials, including our updated guidance.